Cargando…
244P Alternate-day hypofractionated radiotherapy for radical treatment of head & neck cancer during the COVID-19 pandemic: A single institute experience
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719674/ http://dx.doi.org/10.1016/j.annonc.2022.10.279 |
| _version_ | 1784843377370464256 |
|---|---|
| author | Singh, P. Joseph, D.M. Krishnan, A.S. Ahuja, R. Gupta, S. Gupta, M. |
| author_facet | Singh, P. Joseph, D.M. Krishnan, A.S. Ahuja, R. Gupta, S. Gupta, M. |
| author_sort | Singh, P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9719674 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97196742022-12-05 244P Alternate-day hypofractionated radiotherapy for radical treatment of head & neck cancer during the COVID-19 pandemic: A single institute experience Singh, P. Joseph, D.M. Krishnan, A.S. Ahuja, R. Gupta, S. Gupta, M. Ann Oncol Article Published by Elsevier Ltd. 2022-11 2022-12-04 /pmc/articles/PMC9719674/ http://dx.doi.org/10.1016/j.annonc.2022.10.279 Text en Copyright © 2022 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Singh, P. Joseph, D.M. Krishnan, A.S. Ahuja, R. Gupta, S. Gupta, M. 244P Alternate-day hypofractionated radiotherapy for radical treatment of head & neck cancer during the COVID-19 pandemic: A single institute experience |
| title | 244P Alternate-day hypofractionated radiotherapy for radical treatment of head & neck cancer during the COVID-19 pandemic: A single institute experience |
| title_full | 244P Alternate-day hypofractionated radiotherapy for radical treatment of head & neck cancer during the COVID-19 pandemic: A single institute experience |
| title_fullStr | 244P Alternate-day hypofractionated radiotherapy for radical treatment of head & neck cancer during the COVID-19 pandemic: A single institute experience |
| title_full_unstemmed | 244P Alternate-day hypofractionated radiotherapy for radical treatment of head & neck cancer during the COVID-19 pandemic: A single institute experience |
| title_short | 244P Alternate-day hypofractionated radiotherapy for radical treatment of head & neck cancer during the COVID-19 pandemic: A single institute experience |
| title_sort | 244p alternate-day hypofractionated radiotherapy for radical treatment of head & neck cancer during the covid-19 pandemic: a single institute experience |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719674/ http://dx.doi.org/10.1016/j.annonc.2022.10.279 |
| work_keys_str_mv | AT singhp 244palternatedayhypofractionatedradiotherapyforradicaltreatmentofheadneckcancerduringthecovid19pandemicasingleinstituteexperience AT josephdm 244palternatedayhypofractionatedradiotherapyforradicaltreatmentofheadneckcancerduringthecovid19pandemicasingleinstituteexperience AT krishnanas 244palternatedayhypofractionatedradiotherapyforradicaltreatmentofheadneckcancerduringthecovid19pandemicasingleinstituteexperience AT ahujar 244palternatedayhypofractionatedradiotherapyforradicaltreatmentofheadneckcancerduringthecovid19pandemicasingleinstituteexperience AT guptas 244palternatedayhypofractionatedradiotherapyforradicaltreatmentofheadneckcancerduringthecovid19pandemicasingleinstituteexperience AT guptam 244palternatedayhypofractionatedradiotherapyforradicaltreatmentofheadneckcancerduringthecovid19pandemicasingleinstituteexperience |